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Abstract. 
 
We recently developed an assay in which nu-
clear export of the shuttling transcription factor NFAT 
(nuclear factor of activated T cells) can be reconsti-
tuted in permeabilized cells with the GTPase Ran and 
the nuclear export receptor CRM1. We have now used 
this assay to identify another export factor. After prein-
cubation of permeabilized cells with a Ran mutant that 
cannot hydrolyze GTP (RanQ69L), cytosol supports 
NFAT export, but CRM1 and Ran alone do not. The 
RanQ69L preincubation leads to accumulation of 
CRM1 at the cytoplasmic periphery of the nuclear pore 
complex (NPC) in association with the p62 complex 
and Can/Nup214. RanGTP-dependent association of 
CRM1 with these nucleoporins was reconstituted in 
vitro. By biochemical fractionation and reconstitution, 
we showed that RanBP1 restores nuclear export after 
the RanQ69L preincubation. It also stimulates nuclear 
export in cells that have not been preincubated with 
RanQ69L. RanBP1 as well as Ran-binding domains of 
the cytoplasmic nucleoporin RanBP2 promote the re-
lease of CRM1 from the NPC. Taken together, our re-
sults indicate that RanGTP is important for the target-
ing of export complexes to the cytoplasmic side of the 
NPC and that RanBP1 and probably RanBP2 are in-
volved in the dissociation of nuclear export complexes 
from the NPC in a terminal step of transport.
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 transport between the cytoplasm and
the nucleus is mediated by nuclear pore com-
plexes (NPCs;
 
1
 
 for reviews see Doye and Hurt,
1997; Nigg, 1997), large supramolecular structures that
span the nuclear envelope (NE). Molecules of up to 20-40
kD can passively diffuse through the NPC, whereas larger
molecules, including most proteins and RNAs, are trans-
ported through the NPC by signal- and energy-dependent
mechanisms. In most cases, signal-mediated nuclear im-
port and export appear to involve nucleocytoplasmic shut-
tling receptors of the importin 
 
b
 
 family, which bind to
their cargoes either directly or via adaptor molecules (for
reviews see Görlich and Mattaj, 1996; Nigg, 1997; Mattaj
and Englmeier, 1998). After cargo molecules interact with
their cognate receptors in the originating compartment,
the transport complexes appear to undergo stepwise trans-
location through the NPC to the destination compartment,
whereupon the cargo dissociates from the receptor and the
latter is recycled. Several different classes of transport sig-
nals have been described for nuclear import (nuclear lo-
calization signals, or NLSs) and export (nuclear export sig-
nals, or NESs). A common type of NLS (the “classical”
NLS) comprises a short amino acid sequence enriched in
basic amino acids, and interacts with the import receptor
importin 
 
b
 
 via importin 
 
a
 
, which acts as an adaptor. A
common type of NES is a short peptide segment enriched
in leucine residues (for review see Gerace, 1995), which in-
teracts directly with the export receptor CRM1 (Fornerod
et al., 1997a; Fukuda et al., 1997; Stade et al., 1997).
The NPC (for reviews see Rout and Wente, 1994; Doye
and Hurt, 1997) has an estimated mass of 
 
z
 
125 MD in ver-
tebrate cells. It consists of nucleoplasmic and cytoplasmic
rings flanking eight central spokes, which surround a cen-
tral gated channel that is the site of signal-mediated trans-
port. Emanating outward from the nucleoplasmic and cy-
toplasmic rings are 
 
z
 
50–100-nm-long fibrils, which may
represent initial binding sites for transport complexes at
the NPC. The NPC is thought to be composed of 
 
z
 
50–100
different proteins (nucleoporins). A substantial number of
different nucleoporins have been molecularly character-
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ized in vertebrates and yeast. Of particular interest are a
group of NPC proteins containing multiple copies of FG
(phenylalanine, glycine) repeats dispersed throughout a
portion of their sequence. Some members of this group
have been found to bind directly to nuclear transport fac-
tors in vitro, including importin 
 
b
 
-like receptors (Iovine et
al., 1995; Radu et al., 1995; Rexach and Blobel, 1995; Hu et
al., 1996). Moreover, some FG repeat proteins have been
implicated in nuclear import/export in functional studies
(see Nigg, 1997). This indicates that FG repeat nucleo-
porins constitute at least some of the binding sites for nu-
clear transport complexes at various stages of movement
through the NPC. In vertebrate cells, some FG repeat
nucleoporins are localized to the nucleoplasmic fibrils
(Nup153 [Cordes et al., 1993; Sukegawa and Blobel, 1993],
and Nup98 [Radu et al., 1995]), some are found in the cy-
toplasmic fibrils (RanBP2 [Yokoyama et al., 1995; Wilken
et al., 1995; Wu et al., 1995] and Can/Nup214 [Panté et al.,
1994]) and one (the p62 complex, consisting of four differ-
ent FG repeat proteins; Finlay et al., 1991; Hu et al., 1996;
Hu and Gerace, 1998) is localized near the central gated
channel on both sides of the NPC (Guan et al., 1995).
However, detailed roles of individual FG repeat proteins
in specific transport pathways are not understood.
The small GTPase Ran, which shuttles between the nu-
cleus and the cytoplasm, plays a key role in determining
the vectoriality of nuclear transport (for reviews see Mel-
chior and Gerace, 1998; Moore, 1998). Many importin
 
b
 
-related nuclear transport receptors are RanGTP bind-
ing  proteins (Wozniak et al., 1998), but the binding of
RanGTP has distinct effects on import and export recep-
tors in vitro: RanGTP dissociates cargo from nuclear im-
port receptors (Rexach and Blobel, 1995; Izaurralde et al.,
1997), whereas it promotes the association of cargo with
nuclear export receptors (Fornerod et al., 1997a; Kutay et
al., 1997, 1998; Arts et al., 1998). Since the GTPase-activat-
ing protein for Ran (RanGAP; Coutavas et al., 1993; Bi-
schoff et al., 1995) is sequestered in the cytoplasm and its
guanine nucleotide exchange factor (RCC1) is restricted
to the nucleus (Ohtsubo et al., 1989), most nuclear Ran is
probably in the GTP-bound form, whereas most cytoplas-
mic Ran is likely to be in the GDP-bound form. Thus, the
nucleocytoplasmic compartmentalization of Ran effec-
tors in cells and the resulting asymmetric distribution of
RanGTP appear to be important for the loading/unload-
ing of nuclear transport receptors in the nucleus. It re-
mains possible that Ran has additional functions for speci-
fying the vectoriality of nuclear transport, although these
are not yet characterized. Nuclear import of the import re-
ceptors importin 
 
b
 
 and transportin (by themselves) does
not strictly depend on Ran (Kose et al., 1997; Nakielny
and Dreyfuss, 1998), and transportin-mediated import of
cargo also does not require Ran under certain in vitro con-
ditions (Englmeier at al., 1999; Ribbeck et al., 1999). On
the other hand, since RanGTP and cargo molecules bind
cooperatively in vitro to several export receptors, includ-
ing CRM1 (Fornerod et al., 1997a), exportin-t (Arts et al.,
1998; Kutay et al., 1998), and CAS (Kutay et al., 1997), a
trimeric cargo/RanGTP/receptor complex is likely to be
the form that is actually translocated through the NPC to
the cytoplasm. Whether RanGTP has a role in the translo-
cation itself is unknown.
A major fraction of RanGAP is bound to the cytoplas-
mically oriented nucleoporin RanBP2 due to its modifica-
tion by the ubiquitin-related modifier SUMO-1 (Matunis
et al., 1996; Mahajan et al., 1997), and the remainder of
RanGAP is soluble in the cytoplasm. RanBP2 has four
RanGTP-binding domains (RBDs), which are similar in
sequence to the RBD of the cytosolic protein RanBP1, a
RanGTP-binding protein of 28 kD that stimulates the ac-
tivity of RanGAP (Coutavas et al., 1993; Bischoff et al.,
1995b). A number of studies in yeast (Schlenstedt et al.,
1995) and in higher eukaryotes (Chi et al., 1996; Pu and
Dasso, 1997), support the notion that RanBP1 has a role in
some aspect of nuclear trafficking, but its precise mecha-
nism of action is not known. RanBP1 can release RanGTP
from certain importin 
 
b
 
-type receptors, and it has been
proposed that one function of this protein is to promote
the termination of nuclear export pathways in the cytosol
by disassembling export complexes and triggering Ran-
GTP hydrolysis (Bischoff and Görlich, 1997).
We recently developed an in vitro assay for nuclear pro-
tein export (Kehlenbach et al., 1998), which involves HeLa
cells that are stably transfected with the shuttling tran-
scription factor NFAT (nuclear factor of activated T cells)
fused to the green fluorescent protein (GFP). NFAT con-
tains a leucine-rich NES similar to that found in Rev, PKI,
and a growing number of other proteins. After preincuba-
tion of permeabilized cells with ATP to deplete endoge-
nous export factors, we found that the addition of the
GTPase Ran and the nuclear export receptor CRM1 is
sufficient to reconstitute the nuclear export of GFP-
NFAT. We have now developed a new preincubation con-
dition to make other export factors rate limiting. This in-
volves treatment of permeabilized cells with RanQ69L, a
Ran mutant that is deficient in GTP hydrolysis (Klebe et
al., 1995). Under these conditions, we identified RanBP1
and the RanBP1-like domains of RanBP2 as potent stimu-
lators of nuclear export in vitro. RanBP1 also stimulates
nuclear export in cells that have not been preincubated
with RanQ69L. Our data indicate that RanBP1 and proba-
bly RanBP2 are involved in releasing transport complexes
from the cytoplasmic side of the NPC in a terminal step of
export. In addition, our work suggests that RanGTP is im-
portant for targeting export complexes to the cytoplasmic
side of the NPC, delineating a new potential role for Ran
in promoting the vectoriality of nuclear export.
 
Materials and Methods
 
Nuclear Export Assay
 
HeLa cells, stably transfected with GFP-NFAT (Kehlenbach et al., 1998),
were grown in Dulbecco’s modified Eagle medium (GIBCO BRL) with
10% fetal bovine serum on plastic dishes. Treatment of intact cells with
trichostatin A (Wako BioProducts) to induce expression of GFP-NFAT,
and with ionomycin (Calbiochem Corp.) to induce import of GFP-NFAT
into the nucleus was done as described (Kehlenbach et al., 1998). As indi-
cated, permeabilized cells were subjected to a preincubation step in the
presence of ATP, either including or excluding RanQ69L and cytochrome
c-NES (cc-NES) at final concentrations of 20–25 and 100 
 
m
 
g/ml, respec-
tively. After preincubation, cells were washed twice with transport buffer
(20 mM Hepes-KOH, pH 7.3, 110 mM KOAc, 2 mM Mg[OAc]
 
2
 
, 2 mM
DTT, and 1 
 
m
 
g/ml each of leupeptin, pepstatin, and aprotinin). Nuclear
export reactions and quantitation of nuclear export by flow cytometry
were performed as described (Kehlenbach et al., 1998). 
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Antibodies, SDS-PAGE, and Immunoblotting
 
The anti–CRM1 peptide antibody was described in Kehlenbach et al.
(1998). For immunoprecipitation, immunofluorescence, and immunogold-
EM, the antibody was affinity purified on a column consisting of the
COOH-terminal peptide against which it was raised, coupled to CNBr-
Sepharose 4B (Pharmacia LKB Biotechnology Inc.). The anti–RanBP1
antibody was raised in rabbits and affinity purified using recombinant
RanBP1 coupled to CNBr-Sepharose 4B. Anti–Can/Nup214 antibody was
kindly provided by Dr. Gerard Grosveld. The monoclonal antibodies RL1
and mAb414 were from Affinity BioReagents, Inc. and BAbCO, respec-
tively. The monoclonal anti-importin 
 
b
 
-antibody (ascites fluid; Affinity
BioReagents, Inc.) used for immunoprecipitations was diluted 1:1 with
5 mg/ml BSA in transport buffer. The polyclonal anti-importin 
 
b
 
-anti-
body used for immunoblots was raised against recombinant glutathione-
 
S
 
-transferase (GST)–tagged protein and purified using recombinant 6
 
3
 
His-tagged protein.
For immunoblotting, proteins were separated by SDS-PAGE and elec-
trophoretically transferred onto nitrocellulose using standard methods.
Blots were blocked with 5% milk powder in TBST (10 mM Tris-HCl, pH
8, 150 mM NaCl, 0.05% Tween 20) overnight. HRP-coupled goat anti–
mouse or donkey anti–rabbit IgG (Pierce Chemical Co.; 1:10,000 in 10
mM Tris-HCl, pH 8, 150 mM NaCl, 0.05% Tween 20) were used as sec-
ondary antibodies. The enhanced chemiluminescence system (Pierce
Chemical Co.) was used for visualization of proteins.
 
Nuclear Transport Factors
 
Recombinant wild-type Ran and RanQ69L were prepared as described
(Melchior et al., 1995). For preparation of GST-Ran, the cDNA was
cloned into a pGEX-2T (Pharmacia LKB Biotechnology Inc.)–derived ex-
pression vector. The protein was expressed in 
 
Escherichia coli
 
 and puri-
fied using glutathione-Sepharose beads (Pharmacia LKB Biotechnology
Inc.). To load Ran with nucleotides,
 
 
 
soluble protein (1 mg/ml) was treated
with 10 mM EDTA, 2 mM DTT, and 2 mM GDP or GMP-PNP. Nucle-
otides were added from a 20-mM stock in 20 mM Hepes-KOH, pH 7.2,
and 20 mM MgCl
 
2
 
. After 30 min at 30
 
8
 
C, MgCl
 
2
 
 was added to a final con-
centration of 20 mM and the sample was diluted with an equal volume of
transport buffer to 0.5 mg Ran/ml. For loading of GST-Ran, the protein
was first bound to glutathione-Sepharose beads (Pharmacia LKB Biotech-
nology Inc.) at 3 mg/ml of packed beads. After incubation with 2 mM
GMP-PNP, 10 mM EDTA, and 2 mM DTT for 30 min at 30
 
8
 
C, 20 mM
MgCl
 
2 
 
was added and the beads were washed with transport buffer.
Recombinant RanBP1 (purified by ammonium sulfate precipitation,
ion exchange chromatography, and gel filtration) was kindly provided by
Dr. R. Mahajan (The Scripps Research Institute). GST-tagged p62, p58,
and p54 were expressed and purified as described in Hu et al. (1996). A
6
 
3 
 
His-tagged COOH-terminal fragment of Can/Nup214 (amino acids
1861–2090) was cloned into pTrcHisA (Invitrogen Corp.). 6
 
3 
 
His-Can/
Nup214 and the 6
 
3 
 
His-tagged RBD1 of RanBP2 (amino acids 1155–1321;
in pET28; Novagen, Inc.) were purified using Ni-NTA Superflow-beads
(QIAGEN Inc.), according to the manufacturer’s instructions. Native
CRM1 was partially purified by ammonium sulfate precipitation and ion-
exchange chromatography as described (Kehlenbach et al., 1998), dia-
lyzed against transport buffer and frozen in liquid N
 
2
 
 at 
 
z
 
160 
 
m
 
g CRM1/
ml (as compared by SDS-PAGE to a BSA standard). Aliquots were
stored at 
 
2
 
80
 
8
 
C. When samples were analyzed by SDS-PAGE followed
by Coomassie staining, CRM1 appeared as the most abundant protein
with an estimated purity of 
 
z
 
60–70%.
 
Preparation of Cytochrome c-NES
 
To prepare cc-NES, 5 mg cytochrome c (Sigma Chemical Co.) in 1.4 ml
PBS was activated with 7 mM sulfo-SMCC (Pierce Chemical Co.) for 1 h
at room temperature. Free crosslinker was removed by chromatography
over a PD10 column (Pharmacia LKB Biotechnology Inc.) equilibrated
with PBS. 2 mg of NES-peptide (the Rev-sequence CLPPLERLTL, syn-
thesized at the Scripps Core Facility) was added and the reaction was in-
cubated overnight at 4
 
8
 
C. Free peptide was then removed by chromatog-
raphy over a PD10 column equilibrated with transport buffer, and the
protein (
 
z
 
2 mg/ml) was stored at 4
 
8
 
C.
 
Fractionation of Cytosol
 
Cytosol was prepared as described (Kehlenbach et al., 1998) and dialyzed
into triethanolamine buffer (20 mM triethanolamine, pH 7.4, 2 mM
MgCl
 
2
 
). To isolate the cytosolic factor that restores transport after prein-
cubation of cells in the presence of RanQ69L, cytosol (10 mg of protein)
was loaded on a FPLC Mono Q column (HR 5/5; Pharmacia LKB Bio-
technology Inc.) and 1-ml fractions were eluted with an 18-ml linear gradi-
ent of 0 to 500 mM NaCl in triethanolamine buffer at a flow rate of 0.4 ml/
min. Maximal nuclear export activity was recovered around 280 mM
NaCl. 900 
 
m
 
l of the fraction containing peak activity (as determined by the
nuclear export assay) was concentrated to 300 
 
m
 
l by vacuum dialysis and
applied to a gel filtration column (Superdex 200 HR 10/30; Pharmacia
LKB Biotechnology Inc.) equilibrated in transport buffer. The sample
was chromatographed at 0.4 ml/min and 0.5-ml fractions were collected.
The nuclear export activity eluted with an apparent molecular mass of
 
z
 
30 kD.
 
Immunofluorescence Microscopy and Immunogold-EM
 
For immunofluorescence staining, digitonin-permeabilized cells were al-
lowed to bind to poly lysine–coated coverslips for 15 min at 4
 
8
 
C, fixed for
6 min with 4% formaldehyde in PBS at 20
 
8
 
C, and then treated with 0.2%
Triton X-100 in PBS for 5 min at 20
 
8
 
C. After washing, cells were incu-
bated with purified anti–CRM1 antibody at 1–2 
 
m
 
g/ml for 1 h at 20
 
8
 
C in
2% BSA in PBS. Texas red donkey anti–rabbit IgG (Pierce) was used as
secondary antibody. Confocal microscopy was performed using an
MRC1024 (Bio-Rad Laboratories) attached to an Axiovert S100TV (Carl
Zeiss, Inc.). Microscopic parameters were identical for pairs of pictures.
Digital data were processed identically, using Adobe Photoshop (Adobe
Systems Inc.).
To carry out immunogold-localization, cells were permeabilized by one
cycle of freeze-thawing and incubated in transport buffer with anti–CRM1
antibody (2 
 
m
 
g/ml) for 2–3 h. Samples were washed and incubated with
anti–rabbit IgG coupled to 5 nm gold (Sigma Chemical Co.) as secondary
antibody. After washing with transport buffer, cells were fixed with 2%
glutaraldehyde for 15 min, postfixed with 1% osmium tetroxide, and
stained en block with 1% uranyl acetate. Cells were then dehydrated in
serial ethanol concentrations and embedded in Eponate 812 (Ted Pella,
Inc.). Thin sections were analyzed using a Phillips EM 208, without fur-
ther staining. All steps were performed at room temperature.
 
Immunoprecipitation
 
For immunoprecipitation, 4 
 
3 
 
10
 
6
 
 digitonin-permeabilized cells were solu-
bilized for 20 min on ice in 1 ml NP40 buffer (1% NP40, 50 mM Tris-HCl,
pH8, 5 mM EDTA, 5 mM EGTA, 15 mM MgCl
 
2
 
, 60 mM 
 
b
 
-glycerophos-
phate, 100 
 
m
 
M KF, 100 
 
m
 
M NaVO
 
4
 
,
 
 
 
2 mM DTT,
 
 
 
1 
 
m
 
g/ml each of leupep-
tin, pepstatin, aprotinin, and 300 mM NaCl). After centrifugation at
100,000
 
 g
 
 for 30 min at 4
 
8
 
C, purified anti–CRM1 antibody (10 
 
m
 
g/ml) or
anti–importin 
 
b
 
 antibody (ascites fluid, 1:100) was added. Samples were
incubated at 4
 
8
 
C for 2 h and immunoreactive proteins were collected with
protein A–Sepharose (Pharmacia LKB Biotechnology Inc.). The beads
were washed four times with NP40 buffer and precipitated proteins were
analyzed by SDS-PAGE, followed by immunoblotting or silver staining.
 
In Vitro Binding and Release Experiments
 
To analyze the binding of NE-proteins to immobilized CRM1, 30 
 
m
 
g
of purified anti–CRM1 antibody was first bound to 60 
 
m
 
l protein
A–Sepharose beads. 2 
 
3 
 
10
 
7
 
 digitonin-permeabilized HeLa cells were sol-
ubilized in NP40 buffer containing 300 mM NaCl and centrifuged at
100,000 
 
g
 
 for 30 min. To load the protein A-anti–CRM1 beads with
CRM1, beads were incubated with the permeabilized cell supernatant for
90 min at 20
 
8
 
C, and then washed four times with NP40 buffer. Only bands
corresponding to CRM1 and IgG could be detected when a sample of
these beads was analyzed by SDS-PAGE, followed by blotting and Pon-
ceau staining. Nuclear envelopes were prepared as described (Gerace et
al., 1978) and stored at 
 
2
 
80
 
8
 
C. 200 OD
 
260
 
 U of NE (derived from 
 
z
 
6 
 
3
 
10
 
8
 
 nuclei) were solubilized on ice for 20 min in 1 ml NP40 buffer contain-
ing 450 mM NaCl. After centrifugation at 100,000 
 
g 
 
for 30 min, the super-
natant was diluted with NP40 buffer without NaCl to 150 mM NaCl. 60 
 
m
 
l
of this extract was added to 6 
 
m
 
l protein A-CRM1 beads in the absence or
presence of 25 
 
m
 
g/ml RanGDP or RanGMP-PNP and 100 
 
m
 
g/ml cc-NES.
NP40 buffer containing 150 mM NaCl, and BSA (final concentration of 10
mg/ml) was added to give a final volume of 250 
 
m
 
l. After incubation at
20
 
8
 
C for 1 h, beads were washed four times with NP40 buffer containing
150 mM NaCl and bound proteins were analyzed by SDS-PAGE, fol-
lowed by immunoblotting. 
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For binding experiments using purified CRM1 and GST-p62, GST-p58,
GST-p54, or 6
 
3
 
His-Can/Nup214, the recombinant proteins were bound
to glutathione-Sepharose beads or Ni-NTA-superflow beads (QIAGEN
Inc.) at 50–100 
 
m
 
g/ml. The beads were then treated with 30 mg/ml BSA in
transport buffer for 20 min to block nonspecific binding sites. 5 
 
m
 
l CRM1
(
 
z
 
160 
 
m
 
g/ml) was added to 6 
 
m
 
l of beads in the absence or presence of 25
 
m
 
g/ml RanGDP or RanGMP-PNP and 1 mg/ml NES-peptide (CLPPLER-
LTL; from a 2-mg/ml stock in transport buffer) in a total volume of 100 
 
m
 
l
containing 10 mg/ml BSA. After 90 min at 20
 
8
 
C, the beads were washed
with transport buffer three times. All buffers involving Ni-beads con-
tained 20 mM imidazole. The amount of bound CRM1 was analyzed by
SDS-PAGE and immunoblotting.
To analyze the release of CRM1 from RanGMP-PNP by RanBP1, 
 
z
 
1
 
m
 
g of purified CRM1 was bound to 6 
 
m
 
l GST-RanGMP-PNP beads in the
presence of 1 mg/ml NES peptide and 10 mg/ml BSA in a total volume of
100 
 
m
 
l transport buffer. After extensive washing with transport buffer, the
beads were incubated at 0
 
8 
 
or 30
 
8
 
C with 5 mg/ml BSA and 1 mg/ml NES-
peptide in the absence or presence of 120 
 
m
 
g/ml RanBP1 for 20 min.
These high concentrations of RanBP1 were used because the matrix con-
tains a high concentration of RanGTP, to which RanBP1 and CRM1 can
bind. Released proteins were precipitated with 10% TCA for 5 min on ice
and pelleted by centrifugation at 14,000 
 
g
 
 for 15 min at 4
 
8
 
C. Samples were
analyzed by SDS-PAGE, followed by immunoblotting.
To analyze the release of CRM1 from permeabilized cells after the
RanQ69L preincubation, they were subjected to a second incubation for
15 min in the absence or presence of RanBP1 or RBD1 of RanBP2. The
cells were collected by centrifugation and equivalent amounts of pellet
and supernatant were analyzed by SDS-PAGE, followed by immunoblot-
ting.
 
Results
 
An Assay for an Additional Nuclear Export Factor(s)
 
We previously found that the NES receptor CRM1 and
the small GTPase Ran reconstitute efficient nuclear ex-
port of GFP-NFAT in digitonin-permeabilized HeLa cells
that have been preincubated with ATP at 30
 
8
 
C in order to
deplete shuttling export factors (Kehlenbach et al., 1998).
To identify additional cytosolic export factors besides
CRM1 and Ran, we had to find conditions to make them
rate limiting in our assay. We therefore compared the abil-
ity of CRM1 and cytosol to promote NFAT export in
HeLa cells after various preincubation steps that might
more completely deplete export factors from the perme-
abilized cells.
After our standard preincubation with ATP alone, we
found that either CRM1 alone or cytosol alone stimulated
nuclear export of GFP-NFAT to equivalent levels in the
presence of an excess of wild-type Ran (Fig. 1 a), con-
sistent with our previous work (Kehlenbach et al., 1998).
We then examined the effects of preincubation with
RanQ69L, a mutant form of Ran that is insensitive to Ran-
GAP and therefore is predominantly in the GTP-bound
form (Klebe et al., 1995). RanQ69L has been shown to
promote nuclear export of substrates carrying a leucine-
rich NES (Richards et al., 1997; Kehlenbach et al., 1998)
and to strongly inhibit NLS-mediated nuclear protein
import (Dickmanns et al., 1996; Palacios et al., 1996). Af-
ter preincubation of permeabilized cells with ATP and
RanQ69L, the ability of CRM1 plus wild-type Ran to pro-
mote nuclear export was clearly reduced (Fig. 1 b). In con-
trast, cytosol still retained its strong stimulatory effect on
nuclear export. We next examined the effect of including
an excess of NES substrate in the preincubation, which
would be expected to more fully mobilize the endogenous
export factors. For the NES substrate, we coupled the Rev
NES to cytochrome c, a 12-kD protein that is expected to
enter the nucleus by passive diffusion. Consistent with this
possibility, the Rev-NES conjugate (cc-NES), but not a
conjugate containing an export-defective NES, was able to
compete for nuclear export of GFP-NFAT in vitro (data
not shown). After preincubation of permeabilized cells
with ATP, RanQ69L, and cc-NES, CRM1 and Ran were
no longer sufficient to support any nuclear export of GFP-
NFAT (Fig. 1 c). Under these conditions, the GFP-NFAT
remained in the nucleoplasm (see Fig. 2 b). Again, the ad-
dition of cytosol after this preincubation resulted in a
strong stimulation of nuclear export. However, preincuba-
tion of cells with ATP and cc-NES alone did not affect the
ability of CRM1 and Ran to support nuclear export (data
not shown).
Figure 1. Preincubation of cells with RanQ69L and cc-NES re-
veals a new cytosolic export factor. Permeabilized cells were pre-
incubated with ATP (a), ATP and RanQ69L (b), or ATP,
RanQ69L, and cc-NES (c). Subsequent export reactions were
performed with increasing amounts of cytosol (d) or partially
purified CRM1 (h). All reactions contained 25 mg/ml Ran. Addi-
tion of 100 mg/ml Ran gave essentially the same result (data not
shown). Note that in c the initial level of nuclear fluorescence is
slightly higher than in a and b, presumably because the added cc-
NES prevented export of GFP-NFAT during the preincubation
by competing with the GFP-NFAT. 
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These results clearly demonstrate that cytosol contains
an activity distinct from CRM1 and Ran that is required
for nuclear export of GFP-NFAT after preincubation of
permeabilized cells with RanQ69L. The export substrate
cc-NES potentiates this requirement for an additional fac-
tor when added with RanQ69L in the preincubation. The
cytosolic activity that stimulates export under these condi-
tions could be a nucleocytoplasmic shuttling factor that is
lost from the nuclei during the preincubation. Alterna-
tively, RanQ69L and cc-NES could impose a block on
nuclear export that is efficiently relieved by a cytosolic
factor. In an attempt to distinguish between these pos-
sibilities, we decided to characterize the localization of
GFP-NFAT and of CRM1, the NES receptor for NFAT,
after incubation of permeabilized cells with RanQ69L.
 
RanQ69L Targets CRM1 to the Cytoplasmic Periphery 
of the NPC
 
An export substrate containing a leucine-rich NES has
been shown to bind cooperatively with RanGTP to CRM1
in vitro (Fornerod et al., 1997a), forming a putative nu-
clear export complex. Preincubation of permeabilized cells
with an excess of RanQ69L and cc-NES substrate should
efficiently mobilize CRM1 into export complexes and per-
haps trigger the transport of these complexes out of the
nucleus. As we observed previously (Kehlenbach et al.,
1998), incubation of permeabilized cells at 30
 
8
 
C with ATP
alone (Fig. 2 a, 
 
2 
 
Q69L/cc-NES) led to a depletion of
CRM1 from the cells, as compared with the 0
 
8
 
C control in-
cubation (Fig. 2 a, 0
 
8
 
C). In contrast, incubation with
RanQ69L (Fig. 2 a, 
 
1 
 
Q69L/cc-NES), but not with wild-
type Ran (data not shown), largely prevented the loss of
CRM1 from the permeabilized cells. The high level of
CRM1 retained by preincubation with RanQ69L could re-
sult either from inhibition of export of CRM1 out of the
nucleus or from facilitated recycling/reimport back into
the nucleus. Since incubation of the same number of cells
in a 30-fold larger volume at the same concentration of
RanQ69L did not change the level of CRM1 compared
with the standard RanQ69L incubation as detected by im-
munoblotting (data not shown), RanQ69L appears to act
by inhibiting export of CRM1, rather than by promoting
its reimport. This notion is further validated by the data
shown below. Thus, although RanQ69L promotes efficient
nuclear export of NES-containing substrates in vivo (Rich-
ards et al., 1997), and also a moderate level of nuclear ex-
port in vitro (Kehlenbach et al., 1998), the release of the
nuclear export receptor CRM1 from the permeabilized
cells is impaired by RanQ69L.
We next used immunocytochemical approaches to ex-
amine the localization of CRM1 in the nucleus with and
without preincubation of the cells with RanQ69L. In pre-
vious work, CRM1 was found to be localized throughout
the nucleoplasm as well as at the cytoplasmic and nucleo-
plasmic sides of the NPC in cultured cells (Fornerod et al.,
1997b). Consistent with this, by indirect immunofluores-
cence microscopy, we detected CRM1 predominantly in
the nucleoplasm of digitonin-permeabilized cells (Fig. 2 b,
control). Incubation of cells with RanQ69L, but not with
wild-type Ran (data not shown), led to a strong increase in
staining at the NE together with a decrease in intranuclear
staining (Fig. 2 b, top). The localization of the export sub-
strate GFP-NFAT did not substantially change upon incu-
bation with RanQ69L (Fig. 2 b, middle). Very similar re-
sults were obtained when the cells were incubated with a
combination of RanQ69L and cc-NES (Fig. 2 b, bottom).
When the Triton permeabilization was omitted after the
fixation step before antibody labeling, a similar level of
CRM1 was detected at the NE, even though the NE re-
Figure 2. RanQ69L targets
CRM1 to the cytoplasmic pe-
riphery of the NPC. (a) Perme-
abilized HeLa cells expressing
GFP-NFAT were incubated on
ice or at 308C in either the ab-
sence or presence of a combina-
tion of RanQ69L and cc-NES.
The amount of CRM1 associ-
ated with the cells after the in-
cubations was analyzed by
immunoblotting. (b and c) Per-
meabilized cells were kept on
ice (control) or incubated at
308C with RanQ69L (B, top two
panels) or RanQ69L and cc-
NES (b, bottom, and c as indi-
cated). Cells were analyzed by
fluorescence microscopy to de-
tect CRM1 and GFP-NFAT (b)
or immunogold EM (c) using
purified anti–CRM1 antibodies.
Note that some cells in b do not
express GFP-NFAT (see Keh-
lenbach et al., 1998). Arrows in c
point to NPCs. Bar, 100 nm. 
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mained intact, as demonstrated by the inaccessibility of
nuclear lamins to anti-lamin antibodies (data not shown).
This suggests that CRM1 resides at the cytoplasmic side of
the NPC after the RanQ69L cc-NES incubation.
To further examine the localization of CRM1 under
these conditions, we performed immunogold labeling of
digitonin-permeabilized cells that had been incubated ei-
ther at 0
 
8
 
C in buffer, or at 30
 
8
 
C with RanQ69L and cc-
NES (Fig. 2 c). The nuclei were permeabilized by freeze-
thawing before immunolabeling. Under these conditions,
the nucleoplasmic side of the NPC was freely accessible to
gold probes, as demonstrated by strong labeling of the nu-
cleoplasmic side of the NPC with antibodies to Tpr (data
not shown), which is found on the nuclear side of the NPC
(Cordes et al., 1997). In the control cells, some anti-CRM1
gold labeling was seen throughout the nucleoplasm (not
shown) and gold particles were occasionally found at the
cytoplasmic side of the NPC (e.g., Fig. 2 c, control, right-
most arrow). Strikingly, however, after cells were incu-
bated with RanQ69L, the cytoplasmic periphery of every
NPC was strongly decorated with gold, while essentially
no labeling of the nucleoplasmic side of the NPC was evi-
dent. Labeling was specific, because it was completely
abolished by preincubating the anti-CRM1 antibody with
the peptide against which it had been raised. These results
indicate that CRM1 crosses the NE and accumulates at the
cytoplasmic periphery of the NPC when RanQ69L is
present. Hence, RanQ69L appears to inhibit export by in-
ducing the stable trapping of CRM1 at the cytoplasmic pe-
riphery of the NPC. Since this accumulation is observed
only in the presence of RanQ69L but not wild-type Ran,
the release of CRM1 from this binding site is likely to re-
quire GTP hydrolysis on Ran and/or a cytosolic release
factor that is absent from the permeabilized cells.
 
Can/Nup214 Is the Major Binding Site for CRM1 at the 
Cytoplasmic Site of the NPC
 
We next carried out biochemical analyses to identify the
NPC proteins with which CRM1 associates in the presence
of RanQ69L. Previous work showed that immunoprecipi-
tation of an epitope-tagged version of the nucleoporin
Can/Nup214 from an extract of cultured HeLa cells re-
sulted in the coprecipitation of some CRM1 (Fornerod et
al., 1997). Can/Nup214 is one of the FG-repeat–containing
nucleoporins that is detected by the monoclonal antibod-
ies RL1 (Snow et al., 1987) and mAb414 (Davis and Blo-
bel, 1986). In addition to Can/Nup214, RL1 detects the nu-
cleoporins RanBP2, Nup153, Pom121, Nup98, p62, p58,
and p54 (Snow et al., 1987).
As shown in Fig. 3 a, on silver-stained gels, we detected
two proteins with apparent molecular weights of z70 and
z220 kD (marked by asterisks) that specifically coprecipi-
tated with CRM1 from a cell lysate after preincubation
with RanQ69L at 308C. These bands were not seen after
preincubation at 308C without RanQ69L (when the level
of precipitated CRM1 was reduced due to the loss of
CRM1 from the permeabilized cells under this condition;
compare with Fig. 2 a). Addition of the peptide that had
been used to prepare the anti–CRM1-antibody abolished
the precipitation of CRM1 and also led to the loss of the
coprecipitated proteins, indicating that the latter are in a
complex with CRM1.
In a similar experiment we used immunoblotting with
the RL1 monoclonal antibody to analyze the NPC pro-
teins that coprecipitated with CRM1 (Fig. 3 b). As a con-
trol, we examined the proteins that coprecipitated with the
import receptor importin b. No RL1-reactive proteins
were detectable in the anti–CRM1 immunoprecipitate
from cells that had been incubated in buffer at 08C. In con-
trast, after incubation with ATP, RanQ69L, and cc-NES at
308C, two RL1-positive proteins with the same apparent
molecular weights as the coprecipitated proteins detected
on silver-stained gels (z70 and z220 kD; compare with
Fig. 3 a) were coprecipitated with CRM1. The latter was
identified as Can/Nup214, using a specific antibody against
this protein (data not shown). The 70-kD protein is p62, as
judged by its mobility on SDS-PAGE and by the specific-
ity of RL1. The monoclonal antibody mAb414 detected
the same two proteins as RL1 in these immunoprecipitates
(data not shown). The p58, p54, and p45 subunits of the
p62 complex were not detected in these immunoprecipita-
tion experiments by either RL1 or mAb414 with our im-
munoblotting conditions, probably because larger amounts
of these proteins are required for detection compared with
p62 (see Davis and Blobel, 1986; Snow et al., 1987). How-
ever, since these proteins remain tightly associated with
p62 under similar extraction conditions (Guan et al.,
1995), they most likely are present in the immunoprecipi-
tates with p62. The level of immunoprecipitated CRM1 it-
self in this experiment was the same with or without the
RanQ69L preincubation (Fig. 3 b, bottom left; note the
difference from Fig. 3 a, where both, the 1 and 2
RanQ69L samples were incubated at 308C), consistent
with the finding that CRM1 is retained in the permeabi-
lized cells during the RanQ69L treatment.
As a control, we examined whether RL1 antigens coim-
munoprecipitated with the import receptor importin b un-
der these conditions. In contrast to the results obtained
with CRM1, a distinct set of nucleoporins coprecipitated
with importin b in this experiment. RanBP2 and Nup153
were the only detectable nucleoporins that appeared in
anti–importin b immunoprecipitates from extracts of cells
that had been incubated at 08C (Fig. 3 b). When cells were
preincubated with ATP, RanQ69L, and cc-NES at 308C,
Nup153 no longer coprecipitated with importin b, al-
though the amount of coimmunoprecipitated RanBP2 did
not change significantly. The amount of importin b in the
immunoprecipitate (Fig. 3 b, bottom right) was clearly re-
duced after the RanQ69L incubation, indicating that im-
portin b, unlike CRM1, is depleted from the nucleus under
these conditions. Thus, the export receptor CRM1 and the
import receptor importin b behave differently during pre-
incubation with RanQ69L: RanQ69L promotes the associ-
ation of CRM1 with a subset of cytoplasmic nucleoporins,
but does not promote its release from nuclei, whereas
RanQ69L induces the dissociation of importin b from a
nucleoplasmic nucleoporin (Nup153) and stimulates re-
lease of importin b from the permeabilized cells.
To investigate the binding of CRM1 to proteins of the
NPC under defined in vitro conditions, we immobilized
CRM1 on anti–CRM1 antibodies coupled to Protein A
beads. The beads were then incubated with an NP40 lysate
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RanGDP or RanGMP-PNP, a nonhydrolyzable GTP ana-
logue. In some reactions, we added cc-NES, which en-
hances the binding of RanGMP-PNP to CRM1 (data not
shown). Proteins bound to the CRM1 beads were detected
on immunoblots using the RL1 antibody. In the absence of
added cc-NES, the nucleoporins p62 and Nup153 and a
faint band migrating below Nup153 bound to the beads in
the presence of RanGDP (Fig. 3 c). Very similar levels of
these proteins bound when no exogenous Ran was added
(data not shown). When the incubation contained Ran
that had been loaded with GMP-PNP, Can/Nup214 and an
increased level of p62 bound to the beads. Neither the
level of Nup153 nor of the minor band below Nup153
changed upon addition of RanGMP-PNP. Although addi-
tion of cc-NES to the incubations had no effect when
the samples contained RanGDP, cc-NES increased the
amount of Can/Nup214 and p62 bound to the beads in the
presence of RanGMP-PNP. As a control for the specificity
of binding, we used Protein A beads that had been cou-
pled to rabbit IgG instead of anti–CRM1 antibody, but
were otherwise treated identically. Only a very faint band
corresponding to Nup153 could be detected (data not
shown), indicating that the binding of nucleoporins to the
beads was specific for CRM1. The differential binding of
Nup153 to CRM1 in Fig. 3, b and c, probably results from
the different experimental approaches: in the immunopre-
cipitation experiment (Fig. 3 b), we examined CRM1 that
is associated with proteins of intact NPCs at the end point
of a transport reaction in a permeabilized cell assay. This
reaction leads to accumulation of CRM1 on the cytoplas-
mic side of the NPC, whereas Nup153 is localized to the
nucleoplasmic side. In contrast, in the in vitro binding ex-
periment (Fig. 3 c), solubilized proteins of the NPC are al-
lowed to bind to immobilized CRM1.
We next investigated the binding of partially purified
CRM1 to recombinant proteins of the p62 complex (p54,
p58, and p62) and to a COOH-terminal fragment of Can/
Nup214 that has previously been shown to bind to CRM1
in vivo (Fornerod et al., 1996). In this experiment, the nu-
cleoporins (instead of CRM1) were immobilized on affin-
ity matrices for the binding reactions. As shown in Fig. 3 d,
RanGMP-PNP, but not RanGDP or GMP-PNP alone,
strongly promoted binding of CRM1 to all three proteins
of the p62 complex. The binding was further increased if
an NES peptide was included in the reaction. We detected
substantial binding of CRM1 to the COOH-terminal frag-
ment of Can/Nup214 in the presence of RanGDP or free
GMP-PNP (i.e., in the absence of Ran), and only a modest
increase in binding when RanGMP-PNP was added. No
binding was detected when we used Ni beads that had not
Figure 3. RanQ69L promotes
binding of CRM1 to Can/
Nup214 and p62. (a) Permeabi-
lized HeLa cells were incubated
at 308C in the absence (2) or
presence (1) of RanQ69L. Pro-
teins were immunoprecipitated
from an NP40 lysate (containing
300 mM NaCl) with the anti–
CRM1 antibody in the absence
(2) or presence (1) of the pep-
tide that had been used to raise
the antibody. Precipitated pro-
teins were analyzed by SDS-
PAGE followed by silver stain-
ing. Two coprecipitating proteins
are marked by asterisks. (b) Per-
meabilized HeLa cells were in-
cubated in the absence (2) of
RanQ69L and cc-NES at 08C or
the presence (1) of RanQ69L
and cc-NES at 308C. Proteins
were immunoprecipitated from
an NP40 lysate (containing 300
mM NaCl) using antibodies
against CRM1 or importin b
(imp  b). Precipitated proteins
were detected on immunoblots
using the RL1 antibody (top) or
anti–CRM1 (bottom left) and
anti–importin  b antibodies (bottom right). Essentially the same result as shown in this figure was obtained when the NP40 buffer con-
tained either 150 or 450 mM NaCl (data not shown). (c) Solubilized rat liver NE proteins were incubated in the absence (2) or presence
(1) of RanGDP, RanGMP-PNP, and cc-NES, with CRM1 that had been immobilized on anti–CRM1–Protein A beads. Bound proteins
were detected on immunoblots with the RL1 antibody. No binding of Can/Nup214 was detected with GMP-PNP alone (i.e., when Ran
was omitted in the loading step; data not shown). (d) GST-p54, -p58, -p62, and a 63 His-tagged COOH-terminal fragment of Can/
Nup214 were incubated in the absence (2) or presence (1) of RanGDP, GMP-PNP (Ran was omitted in the loading step), RanGMP-
PNP, and NES peptide. Bound CRM1 was detected on immunoblots using the anti–CRM1 antibody.The Journal of Cell Biology, Volume 145, 1999 652
been coupled with the Can/Nup214 fragment (data not
shown).
In the two different binding reconstitution experiments
(Fig. 3, c and d), RanGMP-PNP stimulated the nucle-
oporin/CRM1 interactions to different levels, depending
on the source of nucleoporins and the nature of the affin-
ity matrix. It strongly enhanced the interaction between
Can/Nup214 and CRM1 when solubilized NEs were used
as a source of nucleoporins (Fig. 3 c), but only modestly
enhanced the interaction when a recombinant fragment of
Can/Nup214 was used (Fig. 3 d). Conversely, RanGMP-
PNP only modestly enhanced the association of p62 with
CRM1 when p62 came from solubilized NEs, but strongly
enhanced the association when recombinant p62, p58, and
p54 were used (Fig. 3 d). Aside from the different nature
of the affinity matrices in the two cases (see Fig. 3, legend),
these differences may be due to the presence of compo-
nents in the solubilized NEs that differentially affect the
binding of Can/Nup214 versus p62 to CRM1. In addition,
the short recombinant fragment from the COOH terminus
of Can/Nup214 might be folded in a way that results in a
different binding activity of the fragment compared with
the full-length protein from NEs.
Despite these quantitative differences, the results of
these in vitro binding reconstitution experiments are in
agreement with the results of the immunoprecipitation ex-
periments involving extracts of permeabilized cells (Fig. 3,
a and b), which showed that RanQ69L induces the stable
binding of CRM1 to Can/Nup214 and p62 in permeabi-
lized cells. The stimulation of binding of CRM1 to these
nucleoporins by RanQ69L/RanGMP-PNP suggests that
these interactions reflect the association of an export com-
plex separately with Can/Nup214 and p62. It remains pos-
sible that a ternary complex of CRM1, p62, and Can/
Nup214 can be formed. However, in light of our EM data,
we think it unlikely that the end point of the transport re-
action in the presence of RanQ69L, which is analyzed in
the immunoprecipitation experiments (Fig. 3, a and b), in-
volves such a complex. This is because much of the CRM1
was found at the periphery of the NPC where Can/Nup214
is localized (Panté et al., 1994), which is distinct from the
central location where p62 is found (Guan et al., 1995).
Significantly, the above results imply that RanGTP not
only promotes the formation of an export complex, but
also targets it to specific sites in the NPC during transport.
Since Can/Nup214 is located in a more peripheral cyto-
plasmic location in the NPC than the p62 complex, it is
likely that the association of the export complex with Can/
Nup214 represents a late step in nuclear export. Release
from this site is mediated by a cytosolic factor, at least in
cells that have been preincubated with RanQ69L, thereby
allowing efficient nuclear export in a subsequent reaction
(see Fig. 1).
RanBP1 Promotes Nuclear Export of GFP-NFAT
To identify the cytosolic factor that restores export of
GFP-NFAT after preincubation of permeabilized cells
with RanQ69L and cc-NES, we fractionated cytosol by
column chromatography and tested individual fractions
for their ability to promote export in the presence of exog-
enous Ran and partially purified CRM1. With analysis by
ion exchange chromatography using a Mono Q column,
we obtained a major peak of export activity in fraction 20,
which eluted from the column at z280 mM NaCl (Fig. 4
a). This peak fraction was further analyzed by gel filtra-
tion on an S200 column. A small peak of export activity
was observed in fraction 19, at the position of a globular
protein of z30 kD (Fig. 4 b). A much larger peak elut-
ing at the same position was obtained when total cytosol
instead of a Mono Q fraction was used for gel filtration
(data not shown). The apparent size of the active protein
eluting from the gel filtration column prompted us to
probe fractions of both purification steps for the presence
of RanBP1, a previously characterized cytosolic RanGTP-
binding protein of 28 kD (Coutavas et al., 1993; Bischoff et
al., 1995b). As shown in Fig. 4, a and b (insets), the peak of
RanBP1 detectable by immunoblotting coincides with the
peak of export activity on both the Mono Q and the gel fil-
tration columns. When the S200 samples were analyzed
by silver staining, a protein with the same mobility as
RanBP1 was the only species that peaked in fraction 19
(data not shown). This protein accounted for z10% of the
total protein in that fraction.
We next tested the ability of recombinant RanBP1 to
stimulate nuclear export of GFP-NFAT after the Ran-
Q69L cc-NES preincubation. We found that a combina-
tion of wild-type Ran and RanBP1 strongly stimulated nu-
clear export (Fig. 4 c). Neither Ran nor RanBP1 alone had
a significant effect. No further stimulation of export was
obtained by adding purified CRM1 to Ran and RanBP1 in
the reconstitution (data not shown). In a titration experi-
ment (data not shown), we found that 50% of the maximal
stimulation was obtained with z2 mg/ml RanBP1. RanBP1
was maximally active at a concentration of z15  mg/ml,
whereas a higher concentration resulted in inhibition of
nuclear export. These results demonstrate that RanBP1
stimulates nuclear export in cells that have been preincu-
bated with RanQ69L and cc-NES, indicating that it re-
lieves the block imposed by these reagents. This raises the
possibility that RanBP1 or related proteins have a role in
nuclear export under normal conditions.
As discussed above (see Fig. 1), Ran and CRM1 sup-
port efficient nuclear export in permeabilized cells that
have been preincubated with ATP alone. Nevertheless,
RanBP1 does have a modest stimulatory effect on nuclear
export in nonpreincubated cells, as demonstrated by the
time course experiment shown in Fig. 4 d (note that
RanQ69L-preincubated cells were used in all other panels
of Fig. 4). Here, incubation of the permeabilized cells for
30 min reduced the nuclear fluorescence from 100 to 37 U
in the presence of RanBP1, but only to 51 U in its absence.
This RanBP1-mediated stimulation of nuclear export by
z30% was obtained in four independent experiments.
The observation that RanBP1 is not absolutely required
for nuclear export under these conditions raised the possi-
bility that another factor might provide RanBP1-like func-
tions when the cells have not been preincubated with
RanQ69L. RanBP2 is a giant nucleoporin that has four
RBDs very similar to that of RanBP1 (Yokoyama et al.,
1995). RanBP2 is localized in close proximity to Can/
Nup214 on the cytoplasmic side of the NPC (Wilken et al.,
1995; Wu et al., 1995; Yokoyama et al., 1995) and is well
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Nup214. In RanQ69L preincubated cells, the RBDs of
RanBP2 are likely to be stably occupied by RanQ69L,
which cannot be readily released because the RanQ69L
mutant is insensitive to RanGAP. This situation would ne-
cessitate the addition of exogenous RanBP1 to promote
export, even though the RBDs of RanBP2 would be avail-
able under normal conditions.
To test whether the RBDs of RanBP2 can function like
RanBP1 in our assay, we expressed them as 63 His-tagged
fusion proteins and tested their ability to stimulate nuclear
export of GFP-NFAT after preincubation of permeabi-
lized cells with RanQ69L and cc-NES. As shown in Fig. 4
e, the combination of RBD1 of RanBP2 and Ran stimu-
lates nuclear export to a similar extent as RanBP1 and
Ran (compare Fig. 4 c). RBDs 2–4 of RanBP2 were
equally effective (data not shown). These results show that
either RanBP1 or the RBDs of RanBP2 can release the
block of nuclear export imposed by preincubating cells
with RanQ69L and cc-NES.
RanBP1 and RBDs of RanBP2 Release CRM1 from 
Can/Nup214 at the Cytoplasmic Periphery of the NPC
RanBP1 has been shown to promote the dissociation of
RanGTP from the importin b-related proteins transportin
and CAS, as well as from importin b itself (in the pres-
ence of importin a; Bischoff and Görlich, 1997). To test
whether RanBP1 has a similar effect on the RanGTP-
CRM1 complex, we bound purified CRM1 to GST-
RanGMP-PNP and examined whether RanBP1 was able
to release the CRM1 in a subsequent incubation. As
shown in Fig. 5 a, RanBP1 released the majority of CRM1
into the supernatant (compare the levels of released and
bound CRM1), whereas very little CRM1 was released in
the absence of RanBP1.
We next tested whether RanBP1 might have a similar
effect on CRM1 that is trapped in a complex with Can/
Nup214 at the cytoplasmic side of the NPC as a conse-
quence of incubation of cells with RanQ69L and cc-NES.
Figure 4. RanBP1 and RanBP1-related domains promote nuclear export in vitro. (a) Activity profile of Mono Q fractions. HeLa cyto-
sol was chromatographed on a Mono Q ion exchange column. 20 ml of individual fractions was dialyzed against transport buffer and
added to nuclear export reactions. (b) Activity profile of Superdex 200 fractions. Nuclear export reactions contained 25 ml of Superdex
200 fractions. (a and b) All reactions contained 25 mg/ml Ran. (Insets) Immunoblots of indicated fractions to detect RanBP1. RanBP1
was not detected in any other fraction. (c and e) Stimulation of nuclear export by RanBP1 (c) and RBD1 (amino acids 1155–1321) of
RanBP2 (e). Reactions contained 25 mg/ml Ran, 25 mg/ml RanBP1, and 7.5 mg/ml RBD1 as indicated. (d) Time course of nuclear export
in the absence (h) or presence (d) of 15 mg/ml RanBP1 using cells that have not been preincubated with RanQ69L. (a–c, and e)
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Since the binding of CRM1 to Can/Nup214 is strongly pro-
moted by RanGTP, the dissociation of RanGTP from
CRM1 would be expected to promote the release of the
latter from the NPC. Indeed, after a first incubation of
permeabilized cells with RanQ69L, a second incubation
with RanBP1 strongly reduced the amount of CRM1 at
the NE as seen by immunofluorescence microscopy (Fig. 5
b). Without RanBP1, cells exhibited a strong nuclear rim
staining for CRM1, very similar to the one obtained with-
out a second incubation (compare with Fig. 2 b). The re-
lease of CRM1 from NE of RanQ69L-preincubated cells
was analyzed also by immunoblotting (Fig. 5 c). Whereas a
major proportion of CRM1 remained associated with the
cells (pellet, P) in the absence of RanBP1, the addition of
RanBP1 resulted in the recovery of most CRM1 in the re-
leased fraction (supernatant, S). A similar effect was ob-
tained with RBD1 of RanBP2 (Fig. 5 c).
Taken together, these results suggest that RanBP1, and
probably the RBDs of RanBP2, are involved in the disas-
sembly of the export complex at a terminal nucleoporin
site (Can/Nup214). RanBP1 and RanBP2 apparently act
by releasing RanGTP from CRM1, thereby promoting re-
lease of the export complex from the NPC and dissocia-
tion of the cargo-receptor complex. If the RBDs of
RanBP2 are occupied by RanQ69L, exogenously added
RanBP1 (or cytosolic RanBP1 in intact cells) or soluble
RBDs of RanBP2 are required to fulfill this function. 
Discussion
Targeting of CRM1 to the Cytoplasmic Periphery of the 
NPC by RanGTP during Nuclear Export
In this study, we used biochemical and functional ap-
proaches to search for new components involved in
CRM1-mediated nuclear export. Our studies were based
on the initial observation that incubation of permeabilized
cells with RanQ69L and cc-NES results in strong inhibi-
tion of CRM1-mediated nuclear export. During this treat-
ment, the nuclear export receptor CRM1 becomes highly
concentrated at the cytoplasmic side of the NPC in associ-
ation with Can/Nup214 and the p62 complex, concomitant
with CRM1 depletion from the nuclear interior. We found
that the cytosolic protein RanBP1 and the RBDs of the
nucleoporin RanBP2 can relieve the transport inhibition
imposed by RanQ69L by releasing CRM1 from the cyto-
plasmic nucleoporins. As discussed below, this indicates
that RanBP1 and probably RanBP2 play a key role in a
terminal step of nuclear export involving export complex
dissociation from the NPC.
Previous studies have indicated that CRM1 binds coop-
eratively to RanGTP and export cargo in the nucleus (For-
nerod et al., 1997b) to form a putative export complex that
is transported through the NPC. Several criteria indicate
that the accumulation of CRM1 at the cytoplasmic side of
the NPC during treatment of permeabilized cells with
RanQ69L and cc-NES reflects terminal stages of nuclear
export, as opposed to initial stages of reimport. First, the
in vitro binding of CRM1 to the cytoplasmic nucleporins
Can/Nup214 and to the p62 complex is promoted by com-
ponents known to be involved in the formation of an ex-
port complex (RanGTP, or analogues thereof, and export
substrate). Similarly, the accumulation of CRM1 at the cy-
toplasmic nucleoporins in permeabilized cells is depen-
dent on RanQ69L, which is effectively locked in the GTP-
bound form, and the block of export by RanQ69L is
potentiated by the export substrate cc-NES. Furthermore,
CRM1 is released from these cytoplasmic sites by RanBP1
and RBDs, a reaction that is compatible with an export in-
termediate but not with an import intermediate. RanBP1
has previously been proposed to have a role in disassem-
bly of nuclear export complexes in the cytoplasm (Bischoff
and Görlich, 1997; also see below).
Whereas Can/Nup214 is localized in the fibrils at the cy-
toplasmic periphery of the NPC, the p62 complex is situ-
ated on both the cytoplasmic and nucleoplasmic sides of
the NPC near the central gated channel (Guan et al.,
1995). Our data are consistent with the possibility that
Can/Nup214 is the terminal binding site for the CRM1 ex-
port complex at the NPC, to which it is transferred after
binding to the cytoplasmically oriented p62 complex. The
apparent flexibility of the cytoplasmic fibrils (Panté and
Aebi, 1996), might allow them to interact with the NPC re-
gion containing the p62 complex, enabling direct transfer
of the export complex to Can/Nup214. The fact that
CRM1 is associated with the p62 complex as well as with
Can/Nup214 in permeabilized cells preincubated with
RanQ69L may be due to the saturation of all available
CRM1 binding sites at Can/Nup214, resulting in the accu-
mulation of CRM1 at a more proximal site (the p62 com-
plex) in the export pathway.
The movement of the CRM1 export complex through
the NPC first must involve its association with nucleoplas-
mic nucleoporins. CRM1 from yeast (Crm1p) has been
shown to interact by a two-hybrid assay with a number of
nucleoporins, including mammalian Nup98 (Neville et al.,
1997), which is localized to the nucleoplasmic side of the
NPC (Radu et al., 1995). Nup153, a protein localized to
Figure 5. RanBP1 and
RBDs of RBP2 release
CRM1 from the NE. (a) Re-
lease of CRM1 from GST-
Ran by RanBP1. Purified
CRM1 was bound to GST-
RanGMP-PNP. Beads were
either kept on ice (08C) or in-
cubated at 308C in the ab-
sence (2) or presence (1) of
120 mg/ml RanBP1. Equiva-
lent amounts of proteins
bound to the beads or re-
leased into the supernatant
were analyzed by immu-
noblotting to detect CRM1.
(b) Detection of CRM1
by immunofluorescence of
RanQ69L cc-NES–preincu-
bated cells after a second in-
cubation in the absence (2
RanBP1) or presence (1 RanBP1) of 20 mg/ml RanBP1. (c)
RanQ69L cc-NES–preincubated cells were subjected to a second
incubation with buffer, 40 mg/ml RanBP1, or 10 mg/ml RBD1 of
RanBP2, as indicated. Equivalent amounts of fractions contain-
ing pelleted cells/nuclei (P) or proteins released into the superna-
tant (S) were analyzed by immunoblotting to detect CRM1.Kehlenbach et al. RanBP1 and RanBP2 in Nuclear Export 655
the nucleoplasmic fibrils (Sukegawa and Blobel, 1993),
may be another one of the nucleoplasmic binding sites for
CRM1 in mammals, since we found that it associates with
CRM1 in vitro (albeit not in a RanGTP-stimulated fash-
ion). An additional site probably is the population of p62
complexes found on the nucleoplasmic side of the gated
channel.
It is striking that CRM1 was not detected on the nucleo-
plasmic side of the NPC after preincubation with Ran-
Q69L. This result may be explained, at least in part, by the
possibility that the affinity of the CRM1 export complex
for cytoplasmic nucleoporins is higher than that for nucle-
oplasmic nucleoporins. In this respect, the p62 complex
found on the cytoplasmic side of the NPC may not be bio-
chemically identical to the nucleoplasmic p62 complex. It
also is possible that RanGTP in export complexes acts at
the central gated channel of the NPC to promote vectorial
movement to the cytoplasm. Whatever the mechanism,
the finding that RanGTP (RanQ69L) strongly promotes
the binding/accumulation of the CRM1 export complex at
the cytoplasmic side of the NPC indicates that RanGTP is
important for the vectorial transfer of the export complex
through the NPC. Thus, these results point to a second im-
portant function for RanGTP in nuclear export, in addi-
tion to its role in promoting the association of export cargo
with CRM1 inside the nucleus.
The behavior of the import receptor importin b was
very different from CRM1 in our studies, arguing that the
nucleoporin associations seen for CRM1 are specific and
functionally relevant. Importin b appears to be more
highly associated with the NPC than CRM1 in cultured
cells at steady state, since substantial association of impor-
tin b with RanBP2 and Nup153 was seen in immunopre-
cipitates of permeabilized cell extracts, whereas no signifi-
cant association of CRM1 with Can/Nup214 or the p62
complex was detected unless cells were pretreated with
RanQ69L. High levels of importin b remained associated
with RanBP2 after treatment with RanQ69L, but the asso-
ciation with Nup153 was no longer seen. These findings
are consistent with previous work showing that adding
GMP-PNP to Xenopus egg lysates results in loss of copre-
cipitation of importin b with Nup153 (Shah et al., 1998),
and that RanGTP strongly promotes the binding of im-
portin b to RanBP2 at the cytoplasmic side of the NPC
in vitro (Delphin et al., 1997). Incubation of cells with
RanQ69L appears to promote the export (recycling) of
importin b, since substantial amounts of the latter are
released from the cells under these conditions. Thus,
RanBP2 may be a terminal NPC binding site for the ex-
port of importin b, much like Can/Nup214 appears to be a
terminal site for CRM1 export. This suggests that the recy-
cling (export) of at least one import receptor uses nucle-
oporin binding sites that are at least partially distinct from
those used by an export complex. Teleologically, it makes
sense that these two pathways would be distinct, so that
protein export would not compete with recycling of import
factors.
Role of RanBP1 and RanBP2 in a Terminal Step of 
Nuclear Export
We have identified RanBP1 as the major cytosolic activity
that relieves the block of nuclear export imposed by
RanQ69L and cc-NES, and showed that it also stimulates
export in cells that have not been preincubated with
RanQ69L. RanBP1 has previously been suggested to have
a role in nuclear import (Chi et al., 1996; Pu and Dasso,
1997) and nuclear assembly (Nicolas et al., 1997; Pu and
Dasso, 1997) in higher eukaryotes. The yeast homologue
of RanBP1, Yrb1p, also has been suggested to play a role
in nuclear protein import and RNA export (Schlenstedt et
al., 1995). However, the molecular basis for these previ-
ously observed functional effects, and whether they are di-
rect or indirect, is not entirely clear.
Recent biochemical studies have provided new insight
on a potential role for RanBP1 in nuclear export. In addi-
tion to its role in activating RanGAP (Coutavas et al.,
1993; Bischoff et al., 1995b), RanBP1 has been found to
reduce the inhibitory effect of certain importin b–related
transport receptors (including CAS, transportin, and im-
portin b itself) on RanGAP (Lounsbury and Macara,
1997; Deane et al., 1997; Görlich et al., 1997). This is a con-
sequence of the ability of RanBP1 to release RanGTP
from these transport receptors (Bischoff and Görlich,
1997). This release reaction could allow the cytosolic
RanBP1 both to promote RanGTP hydrolysis and to stim-
ulate the dissociation of cargo from export complexes,
thereby irreversibly dissociating the export complex. In
this study, we have found that RanBP1 releases RanGTP
from the export receptor CRM1 in a manner similar to
other importin b–like receptors that have been examined.
This not only is likely to promote cargo release from
CRM1, but probably also is responsible for the release of
CRM1 from the NPC, since RanGTP strongly enhances
the association of CRM1 with cytoplasmic nucleoporins.
We also observed some release of CRM1 from immobi-
lized GST-RanGTP using very high concentrations of
RanGAP in vitro (our unpublished observations). Thus,
we cannot rule out that RanGAP also contributes to the
release of CRM1 from the NPC. However, exogenously
added RanGAP, even at high concentrations, gave no
stimulation of nuclear export in nonpreincubated cells
(our unpublished observations). Similarly, in a recent
study, Englmeier et al. (1999) have described a small stim-
ulatory effect of RanBP1, but not of RanGAP, on nuclear
export in vitro. The isolation of a native complex consist-
ing of a nucleoporin, CRM1, export cargo, and RanGTP
will be required for further studies on the function of
RanBP1 and RanGAP.
RanBP1 stimulates nuclear export to a modest level
(z30%) in our in vitro assay when the permeabilized cells
have not been preincubated with RanQ69L and cc-NES.
Under these conditions, RanBP2 most likely fulfills similar
functions as RanBP1, since RBDs of RanBP2 are active
both in releasing CRM1 from NEs and in stimulating nu-
clear export after preincubation with RanQ69L. It is inter-
esting to note that there is no RanBP2 homologue in yeast.
Yeast cells therefore rely on the activity of RanBP1-like
proteins for nuclear import and export (Schlenstedt et al.,
1995). In fact, Yrb1p appears to be the only essential
RanBP1-like protein in yeast. 
Richards et al. (1997) detected efficient export of an
NES-containing reporter protein after injecting RanG19V
into the nuclei of cultured cells. RanG19V, like RanQ69L,The Journal of Cell Biology, Volume 145, 1999 656
is insensitive to RanGAP and is therefore predominantly
in the GTP-bound form. Unlike our in vitro studies involv-
ing incubation of permeabilized cells (depleted of most of
the endogenous Ran) with RanQ69L, the microinjection
studies were done in cells containing a high concentration
of wild-type Ran. Thus, the RBDs of endogenous RanBP1
and RanBP2 may not have been completely blocked by
RanG19V in this study, and this could explain how effi-
cient export could occur in this situation, in contrast to the
results we have obtained in our studies.
We were unable to detect any accumulation of the ex-
port cargo GFP-NFAT at the NE under conditions of
RanQ69L preincubation. This could be due to the vast ex-
cess of cc-NES and/or other endogenous export substrates
in the reaction, which would compete with NFAT for
binding to CRM1. However, even when export complexes
are arrested at the cytoplasmic side of the NPC by
RanQ69L, cargo may slowly dissociate from CRM1 even
though CRM1 remains bound to the NPC. This could ex-
plain results we obtained in our previous study (Kehlen-
bach et al., 1998), in which we found a low but significant
level of nuclear export of GFP-NFAT in the presence of
RanQ69L, allowing a single round of nuclear export but
no recycling of the export receptor.
Our data suggest a working model for CRM1-mediated
nuclear export that is shown in Fig. 6. We propose that an
export complex of cargo, CRM1, and RanGTP that forms
in the nucleus first binds to the nucleoplasmic fibrils of the
NPC. It subsequently is translocated through the central
gated channel via the p62 complex on the nucleoplasmic
and cytoplasmic sides of the NPC, and then associates with
the peripheral nucleoporin Can/Nup214 at a terminal NPC
site. The binding of RanBP2 and/or cytosolic RanBP1 to
the RanGTP in the export complex at this site then disso-
ciates RanGTP from CRM1, leading to the release of the
cargo from CRM1 and, concomitantly, the dissociation of
CRM1 from Can/Nup214. GTP hydrolysis on Ran by cyto-
solic or RanBP2-associated RanGAP would make export
essentially irreversible. Our data suggest a new function
for RanGTP in promoting the vectoriality of nuclear ex-
port: in addition to stimulating the binding of cargo to
CRM1 in the nucleus, RanGTP in an export complex pro-
motes targeting to the cytoplasmic side of the NPC. It will
be interesting to examine whether RanGDP, which might
be part of a nuclear import complex (see Melchior and
Gerace, 1998), could have an analogous role in targeting
the import complex to the nucleoplasmic side of the NPC.
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